RxDoctor Payments Data

Ezana Azene, MD

Vascular & Interventional Radiology · la Crosse, WINPI 1073715975

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (36.7%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Philips North America LLC at 35.6% of the total. 2025 is the largest year on record at $6,411, more than ten times the $204 reported in 2019.

$12,499in general payments, 2019–2025

Across 49 payments — averaging $255.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Philips North America LLC$4K
  • Stryker$3K
  • Endovascular Engineering Inc.$2K
  • Medtronic$1K
  • Inari Medical, Inc.$584
  • Boston Scientific$295
  • plus $1K from 4 others
$151,236in research payments, 2019–2025

Across 145 payments — averaging $1043.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Inari Medical, Inc.$131K
  • Medtronic$9K
  • Endovascular Engineering Inc.$9K
  • Biocompatibles UK Ltd$2K
  • Boston Scientific$900

What the payments were for

  • Consulting fees$8757%
  • Speaking & faculty fees$2,56521%
  • Travel & lodging$4,58237%
  • Food & beverage$3,11125%
  • Education$1,36511%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,499 in reported general payments places this provider in the 75th percentile of 99 vascular & interventional radiology providers in Wisconsin.

See all vascular & interventional radiology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$93,273
Medicare patients
300
Services billed
991

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in la Crosse

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →